AlphaYouSN
Insider selling
Sukumar Nagendran sold $1.2M of Taysha Gene Therapies, Inc. (TSHA) stock
Sukumar Nagendran, President and Head of R&D of Taysha Gene Therapies, Inc. (TSHA), sold 200,000 shares of TSHA stock worth $1.2M, per an SEC Form 4 filed Jul 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Jul 10, 2026.
TSHA has moved -20.5% since the trade date, from $6.34 to $5.04 (Sep 21, 2026 close).
- Traded
- Jul 10, 2026
- Disclosed
- Jul 10, 2026
- Filing delay
- 0 days
- Price since
- -20.5%
- Role
- President and Head of R&D
- Source
- SEC Form 4
More TSHA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.